Key statistics
As of last trade, IGM Biosciences Inc (1K0:FRA) traded at 8.20, 92.49% above the 52 week low of 4.26 set on Nov 28, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.45 |
---|---|
High | 8.45 |
Low | 8.20 |
Bid | 8.15 |
Offer | 8.65 |
Previous close | 8.90 |
Average volume | 262.22 |
---|---|
Shares outstanding | 59.32m |
Free float | 21.99m |
P/E (TTM) | -- |
Market cap | 527.34m USD |
EPS (TTM) | -3.65 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 15:02 GMT.
More ▼
Announcements
- IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at Three Upcoming Investor Conferences
- IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
- IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
- IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the Jefferies Healthcare Conference
- IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
- IGM Biosciences Announces Refocusing of Sanofi Collaboration
- IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
More ▼